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Fig. Surgeons’ badge reading.
Table.
Table.
Factors cited for choosing academic practice Women, % Men, %
Research opportunities 47.9 32.4
Mentorship 54.2 32.4
Teaching opportunities 58.3 39.2
Diversity/complexity of case load 52.1 36.5
Ability to subspecialize 4.2 8.8
Larger call pool 8.3 16.9
Other 2.1 2
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IP147.
No. BMI FT Air kerma
EVAR, mean 6 SD Pre 23 25.8 6 4.7 36.0 6 19.3 1445 6 798Modern Fixed Imaging Systems Reduce
Radiation Exposure to Patients and ProvidersBMI matched,
mean 6 SD
Post 23 25.7 6 4.6 36.5 6 11.9 767 6 649
P value .93 .61 .003
EVAR, mean 6 SD Pre 23 25.9 6 3.5 38.1 6 11.8 1594 6 776
FT matched,
mean 6 SD
Post 23 25.7 6 4.6 38.5 6 11.9 767 6 649
P value .89 .92 <.001
SFA, mean 6 SD Pre 24 28.9 6 6.0 22.3 6 11.6 460 6 369
BMI matched Post 24 29.0 6 6.0 31.1 6 6.2 127 6 72
P value .99 .002 <.0001
SFA , mean 6 SD Pre 24 30.8 6 7.8 31.1 6 6.7 506 6 394
FT matched,
mean 6 SD
Post 24 29.0 6 6.0 31.1 6 6.2 127 6 72
P value .36 .99 <.0001
BMI, Body mass index; EVAR, endovascular aneurysm repair; FT, ﬂuo-
roscopy time; SFA, superﬁcial femoral artery.Lars Stangenberg, MD, PhD1, Fahad Shuja, MD2, Martijn
van der Bom, PhD3, Martine H.G. van Alfen, MSc4, Allen
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Guzman, MD2, Marc L. Schermerhorn, MD2.
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Objectives: Endovascular therapy for aortic and pe-
ripheral interventions is increasingly becoming the ﬁrst-
line treatment modality for a wide array of disease pro-
cesses. High-deﬁnition ﬂuoroscopic imaging is required
to perform these procedures, which are furthermore
growing in complexity, resulting in high radiation exposure
to patient and providers. This is of particular importance
for training institutions as residents and fellows, despite in-
struction in ALARA principles tend, to have high radiation
exposures. Recently, there was an upgrade of the ﬁxed im-
aging system at our institution. We used this opportunity
to compare radiation exposure to patients and providers
before and after the upgrade.
Methods: We performed a retrospective analysis of
consecutive EVAR and SFA interventions at our institution
in the years 2013 to 2014 and created two cohorts: pre and
post upgrade. We analyzed body mass index (BMI), ﬂuo-
roscopy times (FT) and air kerma (AK), and then matched
1:1 based on ﬂuoroscopy times as well as BMI. We also
analyzed individual surgeons’ badge readings. The ﬁxed
imaging system was Allura Xper FD20 and was upgraded
to Allura Clarity FD20 (both Philips Healthcare).
Results: We identiﬁed a total of 76 EVARs (53 pre,
23 post) and 123 SFA interventions (99 pre, 24 post)
yielding cohorts of 23 patients each for EVAR analysis
and of 24 patients each for SFA analysis. Complete data
are shown in the Table. There was a 52% reduction in
AK for EVAR and 72% for SFA interventions, respectively
(P < 0.001 for both). Five of six surgeons experienced a
reduction in their average monthly badge readings after
system upgrade (Fig), most notably the fellow from 512
to 109 mrem (P ¼ .0032).
Conclusions: Aortic and peripheral endovascular inter-
ventions can be performed with reduced radiation exposuretopatients andproviders usingmodernﬁxed imaging systems.
This is of particular importance in light of more complex pro-
cedures such as fenestrated and branched endografting that
will require substantial ﬂuoroscopy to perform.
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Objectives: The efﬁcacy of hyperbaric oxygen therapy
(HBOT) to facilitate wound healing in diabetic lower
Fig. Sample masks (region of interest in black) used for image
analysis. A, Unmarked wound. B, Periwound mask. C, Wound-
bed mask.
Fig 1. Proportion women across vascular interventions by race.
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of HBOT-mediated wound healing is unclear but is
thought to relate to increased reactive oxygen species and
reactive nitrogen species (ROS and RNS). ROS and RNS
lead to many downstream affects that impact wound heal-
ing, including increased growth factors, diminished inﬂam-
matory responses, and improved neovascularization. The
impact of HBOT, however, on tissue perfusion and ﬂow
is not known. The purpose of this pilot study was to ascer-
tain the immediate effects of HBOT on the microvascula-
ture of chronic wounds as assessed by ﬂuorescent
angiography.
Methods: Patients underwent ﬂuorescent angiog-
raphy at 4 different time points: immediately prior and
immediately after the ﬁrst and second HBOT treatments.
Photo imaging with infrared camera began concurrently
with the initiation of the IC-Green injection and lasted
for 2.5 minutes. All videos were analyzed via MATLAB us-
ing a reference image at 65 seconds. The wound bed and
the periwound area were then outlined as masks for the im-
age analysis. The ﬁrst and second derivatives were subse-
quently taken to deﬁne 4 time points of interest: the
onset of inﬂow, the time of maximal inﬂow, the time of
peak intensity, and the time of maximal outﬂow.
Results: Immediately after HBOT, there was evidence
of increased ﬂow. The time at which the maximum rate of
arterial inﬂow and venous outﬂow was achieved occurred
increasingly earlier in response to each HBOT. In addition,
the difference in time at which the maximum rate of arterial
inﬂow and venous outﬂow occur was shortened in response
to cumulative treatments of HBOT, suggesting decreased
overall time in the capillary bed.
Conclusions: This pilot study demonstrates that
HBOT appears to immediately impact the microcirculation
both on an inﬂow (arterial) and outﬂow (venous) level, and
this effect also appears to be cumulative. If such a tissue
response is in fact veriﬁed to be sustained in future study,
this may better explain the beneﬁt of HBOT and may
expand the repertoire of diseases that may serve to beneﬁt
from this modality.
Author Disclosures: V. Chandra: Nothing to disclose;G.
C. Gurtner: Nothing to disclose; T. Lundh: Nothing to
disclose; S. Meyer: Nothing to disclose; J. Parsley:
Nothing to disclose; R. Robertson: Nothing to disclose;
S. Sen: Nothing to disclose; S. Cecilia Sorice: Nothing
to disclose.IP151.Disparities in Patient Selection/Presentation
for Initial Vascular Procedure Between Black
and White Patients
Peter A. Soden, MD1, Sara L. Zettervall, MD1, Sarah E.
Deery, MD2, Kakra Hughes, MD3, Michael Stoner, MD4,
Philip P. Goodney, MD, MS5, Ageliki Vouyouka, MD6,
Marc L. Schermerhorn, MD1. 1Beth Israel Deaconess
Medical Center, Boston, Mass; 2Massachusetts General
Hospital, Boston, Mass; 3Howard University and Hospital,
Washington, D.C.; 4University of Rochester, Rochester,
NY; 5Dartmouth-Hitchcock Medical Center, Lebanon,
NH; 6Mount Sinai Health System, New York, NY
Objectives: Prior literature has documented worse
outcomes for black compared to white patients across a
number of vascular procedures. However, there is a lack
of data on when patients of difference races are selected
to undergo revascularization. The aim of this study is to
evaluate the severity of disease at time of initial major
vascular intervention between black and white patients.
Methods: We identiﬁed black and white patients’
initial procedure from all carotid (endarterectomy and
stent), abdominal aortic aneurysm (AAA-EVAR and open
repair), and peripheral artery (PAD-open and endovascu-
lar) revascularizations in the Vascular Quality Initiative
from years 2009 to 2014. We excluded any patient
with Hispanic ethnicity, suprainguinal-only endovascular
intervention, and PAD procedures for asymptomatic
disease. We then compared baseline characteristics and
disease severity at presentation on a national and regional
level.
Results: We identiﬁed 87,943 patients (9.3% black),
with 37,388 carotid (4.7% black), 18,401 AAA (5.0%
black), and 32,154 PAD revascularizations (17% black).
Black patients were younger (carotid 67 vs 70 years, P <
.001; AAA 70 vs 73,P < .001; PAD 65 vs 69, P < .001,
respectively), more likely to be female (carotid 52% vs
39%, P < .001; AAA 32% vs 21%, P < .001; PAD 47%
vs 36%, P < .001; Fig 1), diabetic (carotid 43% vs 29%, P
< .001; AAA 46% vs 19%, P < .001; PAD 60% vs 57%,
P < .001), and have congestive heart failure (carotid 16%
vs 10%, P < .001; AAA 17% vs 10%, P < .001; PAD
